These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31364599)

  • 1. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.
    Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers.
    Palmer W; Greeley SAW; Letourneau-Freiberg LR; Naylor RN
    J Diabetes Sci Technol; 2020 Sep; 14(5):860-867. PubMed ID: 32680447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes.
    Patel R; Crabtree TSJ; Taylor N; Langeland L; Gazis AT; Mendis B; Wilmot EG; Idris I
    Diabet Med; 2022 May; 39(5):e14793. PubMed ID: 35034388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review.
    Asarani NAM; Reynolds AN; Elbalshy M; Burnside M; de Bock M; Lewis DM; Wheeler BJ
    Acta Diabetol; 2021 May; 58(5):539-547. PubMed ID: 33128136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Safety, and Metabolic Control Among Danish Children and Adolescents with Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems.
    Fagerberg AR; Borch L; Kristensen K; Hjelle JS
    Diabetes Technol Ther; 2024 May; 26(5):287-297. PubMed ID: 38386435
    [No Abstract]   [Full Text] [Related]  

  • 6. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Jalilova A; Pilan BŞ; Demir G; Özbaran B; Balkı HG; Arslan E; Köse SG; Özen S; Darcan Ş; Gökşen D
    Eur J Pediatr; 2024 Jul; 183(7):3095-3103. PubMed ID: 38661816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Custom Features of Do-it-yourself Artificial Pancreas Systems (DIYAPS) on Glycemic Outcomes of People with Type 1 Diabetes.
    Staszak W; Chromik J; Braune K; Arnrich B
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1472-1475. PubMed ID: 34891563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health.
    Lee JM; Newman MW; Gebremariam A; Choi P; Lewis D; Nordgren W; Costik J; Wedding J; West B; Gilby NB; Hannemann C; Pasek J; Garrity A; Hirschfeld E
    Diabetes Technol Ther; 2017 Apr; 19(4):209-219. PubMed ID: 28245152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
    N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany.
    Herzog AL; Busch J; Wanner C; von Jouanne-Diedrich HK
    PLoS One; 2020; 15(12):e0243465. PubMed ID: 33332410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-source Artificial Pancreas Systems Are Safe and Effective When Supported In-clinic: Outcomes in 248 Consecutive Type 1 Diabetes Clients.
    Samuel P; Khan N; Klein G; Skobkarev S; Mammon B; Fournier M; Hawke K; Weissinger A; Elliott T
    Can J Diabetes; 2024 Feb; 48(1):59-65.e1. PubMed ID: 37802366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Evidence of Omnipod
    Forlenza GP; DeSalvo DJ; Aleppo G; Wilmot EG; Berget C; Huyett LM; Hadjiyianni I; Méndez JJ; Conroy LR; Ly TT; Sherr JL
    Diabetes Technol Ther; 2024 Aug; 26(8):514-525. PubMed ID: 38375861
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of "Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes".
    Wilkinson TM; de Bock M
    J Diabetes Sci Technol; 2024 Jul; 18(4):897-898. PubMed ID: 37850586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monthly Video-Consultation for Children With Type 1 Diabetes Using a Continuous Glucose Monitoring System: Design of ViDiKi, a Multimethod Intervention Study to Evaluate the Benefit of Telemedicine.
    Frielitz FS; Müller-Godeffroy E; Hübner J; Eisemann N; Dördelmann J; Menrath I; Katalinic A; Hiort O; von Sengbusch S
    J Diabetes Sci Technol; 2020 Jan; 14(1):105-111. PubMed ID: 31315446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
    Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
    J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.